Blood level of anti-HBS in health care staff of Amirkola Hospital, 2001
Background and Objective: About 3-5% of Iranian general population are carriers of hepatitis B virus and about 15% of infected persons will be prone to chronic hepatitis and get cirrhosis and primary liver carcinoma. Up to now no therapeutic regimen has been introduced to eradicate completely this i...
Guardado en:
Autores principales: | R Savad Koohi, MA Hosseinian |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2003
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d00efdf8d3c54f36985ca3f7fec0bbdc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
por: Izabela Szczygielska, et al.
Publicado: (2020) -
Response to Hepatitis B vaccination in health care workers of Yahyanejad Hospital, Babol, 2002
por: M Kashi Fard, et al.
Publicado: (2004) -
The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
por: Ying Wang, et al.
Publicado: (2021) -
Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Yan-Wei Zhong, et al.
Publicado: (2021) -
Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Sheikh Mohammad Fazle Akbar, et al.
Publicado: (2021)